Literature DB >> 22621795

Intervention to improve adherence to lipid-lowering medication and lipid-levels in patients with an increased cardiovascular risk.

Pythia T Nieuwkerk1, Melchior C Nierman, Maud N Vissers, Mirjam Locadia, Phillip Greggers-Peusch, Léon P M Knape, John J P Kastelein, Mirjam A G Sprangers, Hanneke C de Haes, Erik S G Stroes.   

Abstract

Low levels of statin adherence may compromise treatment outcomes. The aim of this study was to investigate whether nurse-led cardiovascular risk-factor counseling could improve statin adherence and lipid levels without increasing patients' anxiety. Patients with indications for statin therapy for primary or secondary prevention of cardiovascular disease were randomly assigned to receive routine care or extended care (EC) at baseline and at months 3, 9, and 18. Patients in the EC group received a personalized risk-factor passport, showing modifiable and unmodifiable individual risk factors and a graphical presentation of their calculated absolute 10-year cardiovascular disease risk as well as the target risk that could be reached if all modifiable risk factors were optimally treated. Lipid levels were assessed at each visit. Carotid intima-media thickness was measured at baseline and at month 18. Adherence, anxiety, quality of life, symptoms, and smoking status were assessed using a self-administered questionnaire at each visit. A total of 201 patients were included in the study. Statin adherence was significantly higher (p <0.01) and anxiety was significantly lower (p <0.01) in the EC group than in the routine care group. Low-density lipoprotein cholesterol was statistically significantly lower in the EC group than in the routine group (2.66 vs 3.00 mmol/L, respectively, p = 0.024) in primary prevention patients only. Intima-media thickness improved significantly from baseline (p <0.01) in all patients, irrespective of group assignment. In conclusion, cardiovascular risk-factor counseling resulted in improved lipid profiles in primary prevention patients and higher levels of adherence to statins and lower levels of anxiety in all patients.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22621795     DOI: 10.1016/j.amjcard.2012.04.045

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  The new ACC/AHA guidelines on the treatment of dyslipidemia: cons.

Authors:  Alberto Zambon
Journal:  Intern Emerg Med       Date:  2014-12-13       Impact factor: 3.397

2.  Medication adherence in secondary prevention post-myocardial infarction.

Authors:  Javier A Valle; P Michael Ho
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-12

Review 3.  Interventions to improve adherence to lipid-lowering medication.

Authors:  Mieke L van Driel; Michael D Morledge; Robin Ulep; Johnathon P Shaffer; Philippa Davies; Richard Deichmann
Journal:  Cochrane Database Syst Rev       Date:  2016-12-21

Review 4.  Medication adherence in patients with diabetes and dyslipidemia: associated factors and strategies for improvement.

Authors:  Lucas N Marzec; Thomas M Maddox
Journal:  Curr Cardiol Rep       Date:  2013-11       Impact factor: 2.931

5.  Medication non-adherence and blood pressure control among hypertensive migrant and non-migrant populations of sub-Saharan African origin: the RODAM study.

Authors:  Erik Beune; Pythia Nieuwkerk; Karien Stronks; Karlijn Meeks; Matthias B Schulze; Frank P Mockenhaupt; Ina Danquah; Kerstin Klipstein-Grobusch; Peter Agyei-Baffour; Joachim Spranger; Juliet Addo; Liam Smeeth; Charles Agyemang
Journal:  J Hum Hypertens       Date:  2018-10-15       Impact factor: 3.012

Review 6.  Interventions for enhancing medication adherence.

Authors:  Robby Nieuwlaat; Nancy Wilczynski; Tamara Navarro; Nicholas Hobson; Rebecca Jeffery; Arun Keepanasseril; Thomas Agoritsas; Niraj Mistry; Alfonso Iorio; Susan Jack; Bhairavi Sivaramalingam; Emma Iserman; Reem A Mustafa; Dawn Jedraszewski; Chris Cotoi; R Brian Haynes
Journal:  Cochrane Database Syst Rev       Date:  2014-11-20

7.  Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish randomized controlled trial.

Authors:  Ainhoa Oñatibia-Astibia; Amaia Malet-Larrea; Belen Larrañaga; Miguel Ángel Gastelurrutia; Begoña Calvo; Dulce Ramírez; Ignacio Cantero; Ángel Garay; Estibaliz Goyenechea
Journal:  Health Serv Res       Date:  2019-04-07       Impact factor: 3.402

Review 8.  A Metaanalysis of Interventions to Improve Adherence to Lipid-Lowering Medication.

Authors:  Richard E Deichmann; Michael D Morledge; Robin Ulep; Johnathon P Shaffer; Philippa Davies; Mieke L van Driel
Journal:  Ochsner J       Date:  2016

Review 9.  How do we improve patient compliance and adherence to long-term statin therapy?

Authors:  Patricia Maningat; Bruce R Gordon; Jan L Breslow
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

10.  Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients.

Authors:  Peter Willeit; Lena Tschiderer; Michael J Sweeting; Simon G Thompson; Matthias W Lorenz; Elias Allara; Kathrin Reuber; Lisa Seekircher; Lu Gao; Ximing Liao; Eva Lonn; Hertzel C Gerstein; Salim Yusuf; Frank P Brouwers; Folkert W Asselbergs; Wiek van Gilst; Sigmund A Anderssen; Diederick E Grobbee; John J P Kastelein; Frank L J Visseren; George Ntaios; Apostolos I Hatzitolios; Christos Savopoulos; Pythia T Nieuwkerk; Erik Stroes; Matthew Walters; Peter Higgins; Jesse Dawson; Paolo Gresele; Giuseppe Guglielmini; Rino Migliacci; Marat Ezhov; Maya Safarova; Tatyana Balakhonova; Eiichi Sato; Mayuko Amaha; Tsukasa Nakamura; Kostas Kapellas; Lisa M Jamieson; Michael Skilton; James A Blumenthal; Alan Hinderliter; Andrew Sherwood; Patrick J Smith; Michiel A van Agtmael; Peter Reiss; Marit G A van Vonderen; Stefan Kiechl; Gerhard Klingenschmid; Matthias Sitzer; Coen D A Stehouwer; Heiko Uthoff; Zhi-Yong Zou; Ana R Cunha; Mario F Neves; Miles D Witham; Hyun-Woong Park; Moo-Sik Lee; Jang-Ho Bae; Enrique Bernal; Kristian Wachtell; Sverre E Kjeldsen; Michael H Olsen; David Preiss; Naveed Sattar; Edith Beishuizen; Menno V Huisman; Mark A Espeland; Caroline Schmidt; Stefan Agewall; Ercan Ok; Gülay Aşçi; Eric de Groot; Muriel P C Grooteman; Peter J Blankestijn; Michiel L Bots
Journal:  Circulation       Date:  2020-06-17       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.